GO:0018107 peptidyl-threonine phosphorylation

Peptidyl-threonine phosphorylation (GO:0018107) is a fundamental post-translational modification in which a phosphate group is covalently attached to the hydroxyl oxygen of a threonine residue within a protein, yielding peptidyl-O-phospho-L-threonine. This process is a subset of protein phosphorylation and is executed by protein kinases that specifically recognize threonine residues, often in the context of serine/threonine kinase families. Because threonine phosphorylation can rapidly and reversibly alter protein conformation, activity, localization, and interactions, it serves as a key switch in intracellular signaling networks. The importance of peptidyl-threonine phosphorylation extends across all domains of life and is particularly critical in eukaryotes, where it regulates cell cycle progression, stress responses, metabolism, and gene expression. For example, the transcription factor MTF1 is modulated by phosphorylation events that influence its stability and transcriptional activity, with direct consequences for reactive oxygen species (ROS) homeostasis and cell survival in hepatocellular carcinoma. In addition, genome-wide association studies have identified phosphorylation-related genes as susceptibility factors for coronary artery aneurysm in Kawasaki disease, highlighting the role of threonine phosphorylation in vascular inflammation. For researchers, understanding peptidyl-threonine phosphorylation requires integrating knowledge of kinase-substrate specificity, phosphatase counter-regulation, and downstream effector pathways. This article provides a comprehensive overview of the biological process, the genes and proteins involved, its relevance to human disease, and the experimental strategies—including CRISPR-based models—used to dissect its functions.

Peptidyl-threonine phosphorylation is the enzymatic addition of a phosphate group to a threonine residue within a polypeptide chain, resulting in the formation of peptidyl-O-phospho-L-threonine. This modification is a reversible post-translational event that can alter protein function and is a core component of cellular signal transduction.

Peptidyl-threonine phosphorylation is a central regulatory mechanism in eukaryotic cells, controlling processes from cell division to apoptosis. Its dysregulation is directly linked to human diseases, including cancer, where aberrant kinase activity can promote tumor growth and survival. Moreover, genetic variants in phosphorylation-related pathways contribute to inflammatory and cardiovascular conditions such as Kawasaki disease-associated coronary artery aneurysms. Understanding this process is therefore essential for developing targeted therapies and for interpreting genomic and proteomic data in biomedical research.

The following genes encode kinases, phosphatases, and substrates that are directly involved in or regulated by peptidyl-threonine phosphorylation, with relevance to human disease and experimental research.

Peptidyl-threonine phosphorylation is regulated by the opposing activities of protein kinases and phosphatases, which are themselves controlled by upstream signals such as growth factors, stress, and nutrients. For instance, the mTOR pathway integrates nutrient and energy signals to phosphorylate threonine residues on effectors like EIF4EBP1 and RPS6KB1, thereby controlling translation and cell growth. In cancer, mutations or overexpression of kinases such as AKT1 and MAPK1 can lead to constitutive threonine phosphorylation, driving oncogenesis. Additionally, phosphatases like PPP2CA act as tumor suppressors by reversing these modifications. The balance is further fine-tuned by scaffold proteins and subcellular localization, ensuring specificity and temporal control.

Aberrant peptidyl-threonine phosphorylation is a hallmark of many cancers. For example, MTF1 phosphorylation influences its transcriptional activity and affects ROS-mediated cell death in liver hepatocellular carcinoma, suggesting that targeting this modification could sensitize tumors to oxidative stress. Other kinases, such as AKT1 and MAPK1, phosphorylate threonine residues on pro-survival and proliferative proteins, promoting tumor growth.

A genome-wide association study identified novel susceptibility genes associated with coronary artery aneurysm formation in Kawasaki disease, highlighting the role of phosphorylation-related pathways in vascular inflammation. These findings suggest that threonine phosphorylation events may contribute to endothelial dysfunction and immune cell activation in cardiovascular disease.

Threonine phosphorylation is integral to metabolic regulation via AMPK and mTOR pathways, and its dysregulation is linked to insulin resistance and neurodegeneration. For instance, GSK3B-mediated threonine phosphorylation of tau protein is implicated in Alzheimer's disease pathology.

Phospho-specific antibodies that recognize peptidyl-O-phospho-L-threonine are widely used to detect and quantify threonine phosphorylation of specific proteins. Western blotting with these antibodies allows researchers to monitor kinase activity and signaling dynamics in response to stimuli or genetic perturbations.

Large-scale identification of threonine phosphorylation sites is achieved through mass spectrometry, often coupled with phosphopeptide enrichment (e.g., TiO2 or IMAC). This approach provides a global view of signaling networks and can reveal novel substrates and crosstalk.

Genome-wide CRISPR knockout or activation screens can identify genes that regulate threonine phosphorylation levels or that are required for specific phosphorylation-dependent phenotypes. Such screens are powerful for discovering new components of signaling pathways.

Live-cell imaging with fluorescently tagged phospho-binding domains (e.g., FRET biosensors) enables real-time monitoring of threonine phosphorylation dynamics. Functional assays, such as proliferation or apoptosis assays, link phosphorylation events to cellular outcomes.

Researchers studying peptidyl-threonine phosphorylation-related genes often need to determine whether a candidate gene is causally involved in a specific signaling event or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with high precision and reproducibility.

Peptidyl-threonine phosphorylation (GO:0018107) is a fundamental post-translational modification that governs diverse cellular processes and is implicated in major human diseases, including cancer and cardiovascular disorders. Understanding its mechanisms, key genes, and regulatory networks is essential for both basic research and therapeutic development. Advances in CRISPR-based models and phosphoproteomics continue to illuminate new roles for this modification, offering opportunities for targeted interventions.